くすりのしおり

Injection
Published: 3/2021

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Lasvic Intravenous Drip Infusion Kit 150mg
 Active ingredient:
Lascufloxacin hydrochloride
 Dosage form:
Injection
 Print on wrapping:

Effects of this medicine

This medicine is a quinolone class antibacterial agent which inhibits enzymes that bacteria need to grow, and shows bactericidal effect.
It is usually used in the treatment of respiratory infections and otorhinolaryngological infections.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have: QT interval prolongation, hypokalemia, arrhythmia, liver disorder, heart disease such as ischemic heart disease and cardiac failure, myasthenia gravis and Marfan syndrome.
    If you have or have a history of convulsive diseases such as epilepsy.
    If you have or have a history of or family history of aortic aneurysm and aortic dissection.
  • If you are pregnant, possibly pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adults, this medicine is infused via intravenous once daily.
    Period of treatment will be determined based on the efficacy of your response.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include injection site reaction such as injection site erythema, injection site pain, injection site induration, and injection site swelling, diarrhea and rash. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • breathing difficulty, decreased blood pressure, edema, redness [shock, anaphylaxis]
  • sore throat, fever [leukopenia]
  • fever, dry cough, respiratory distress [interstitial pneumonia]
  • chest pain, palpitations, shortness of breath [QT interval prolongation, ventricular tachycardia]
  • sweating, chills, palpitations [hypoglycemia]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.